| Model Number |
VTICM5_12.6 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Blurred Vision (2137); Toxic Anterior Segment Syndrome (TASS) (4469)
|
| Date of Event |
01/19/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H6 - type of investigation: 4110 - lens work order search: no similar complaint type events reported for units within the same lot.Claim# (b)(4).
|
| |
|
Event or Problem Description
|
|
The reporter indicated that the surgeon implanted a 12.6mm vticm5_12.6; -4.5/1.0/109 (sphere/cylinder/axis) implantable collamer lens into the patient's right eye (od) on (b)(6) 2024.The surgeon reports the patient has tass which was noticed on (b)(6) 2024, diagnostics was performed, and steroids were used.Lens remains implanted with a planned replacement.Cause of the event was reported as the device but noted the device did not fail to perform as intended.
|
| |
|
Additional Manufacturer Narrative
|
|
It was later reported that on (b)(6) 2024 the lens was explanted but the problem was not resolved.The cause of the event is now reported as unknown.The surgeon additionally noted "currently in good condition, plans to reoperate after futher observation.Postoperative 1w deposts on lens and cornea, 2w kp pig (+) with complaint of blurrying, 3w with complaints of blurring.Subsequently patient infected with covid 19 and the lens was removed.Claim#: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
H6 - type of investigation 3331 - device history record (dhr) review: based on the results of the investigation, all released devices from the associated work order(s), including the suspected device, have been manufactured within established process parameters and there is no indication that the manufacturing and processing of the device contributed to the complaint issue.Claim# (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Corrected data: supplemental #3 incorrectly listed the claim as (b)(4), this should be corrected to (b)(4).Claim#: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: b5 - it was later reported that 58 postoperative days inflammatory recovery was observed.There are no abnormalities.Patient's postop corneal endothelial density was 2632.Claim#: (b)(4).
|
| |
|
Search Alerts/Recalls
|